Vaccine development technology or R&D roadmaps are pathogen-specific, developed in collaboration with global stakeholders and aim to highlight priority activities to accelerate the pathway to licensure, availability and access in low- and middle-income countries (LMICs).  The target audience is vaccine researchers, funders and product developers. Roadmaps have been developed for several pathogens and can be accessed under ‘Research by disease’.

Pathogen-specific Roadmaps

Sexually-Transmitted Infections

• Gottlieb SL, Deal CD, Giersing B, Rees H, Bolan G, Johnston C, Timms P, Gray-Owen SD, Jerse AE, Cameron CE, Moorthy VS, Kiarie J, Broutet N. The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps. Vaccine. 2016 Jun 3;34(26):2939-2947. doi: 10.1016/j.vaccine.2016.03.111. Epub 2016 Apr 19. PMID: 27105564; PMCID: PMC6759054. 
• Gottlieb SL, Jerse A, Delany-Moretlwe S, Deal C, Giersing  B. Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap. Sex Health. 2019 Sep;16(5):426-432. doi: 10.1071/SH19060. Available at: https://pubmed.ncbi.nlm.nih.gov/31476278/ 

Tuberculosis

• Global Roadmap for Research and Development of Tuberculosis Vaccines. European & Developing Countries Clinical Trials Partnership, April 2021.

Respiratory syncytial virus (RSV)

• A Roadmap for Advancing RSV Maternal Immunization. PATH, October 2018. 

Group B Streptococcus

• Vekemans J, Moorthy V, Friede M, Alderson MR, Sobanjo-Ter Meulen A, Baker CJ, Heath PT, Madhi SA, Mehring-Le Doare K, Saha SK, Schrag S. Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics. Vaccine. 2019 Nov 28;37(50):7391-3. Available at: https://www.sciencedirect.com/science/article/pii/S0264410X17313592

Antimicrobial Resistance

Invasive non-typhoidal Salmonella (iNTS)